Vinflunine
JE Frampton, MD Moen - Drugs, 2010 - Springer
Vinflunine is a novel bifluorinated vinca alkaloid that appears to differ from other class
members in terms of its tubulin-binding properties and inhibitory effects on microtubule …
members in terms of its tubulin-binding properties and inhibitory effects on microtubule …
Vinflunine in the treatment of bladder cancer
M Bachner, M De Santis - Therapeutics and clinical risk …, 2008 - Taylor & Francis
Vinflunine (VFL) is a third-generation bifluorinated semi-synthetic vinca alkaloid obtained by
superacidic chemistry from its parent compound, vinorelbine. As with the other vinca …
superacidic chemistry from its parent compound, vinorelbine. As with the other vinca …
Vinflunine: a fluorinated vinca alkaloid for bladder cancer therapy.
H Gerullis - Drugs of Today (Barcelona, Spain: 1998), 2011 - europepmc.org
Vinflunine is a novel third-generation bifluorinated semisynthetic vinca alkaloid that has
been shown to have activity against a variety of solid tumor types including advanced …
been shown to have activity against a variety of solid tumor types including advanced …
Vinflunine
JA McIntyre, J Castaner - Drugs of the Future, 2004 - access.portico.org
Vinflunine is a second-generation Vinca alkaloid distinguished from other related
compounds by differences in tubulin binding affinities and its effects upon microtubule …
compounds by differences in tubulin binding affinities and its effects upon microtubule …
Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid
FAB Schutz, J Bellmunt, JE Rosenberg… - Expert opinion on drug …, 2011 - Taylor & Francis
Introduction: Vinca alkaloid agents have been widely used in several different types of
malignancies. However, cancer cells, ultimately, develop resistance to these agents …
malignancies. However, cancer cells, ultimately, develop resistance to these agents …
Clinical activity of vinflunine in transitional cell carcinoma of the urothelium and other solid tumors
J Bellmunt, FM Delgado, C George - Seminars in oncology, 2008 - Elsevier
Vinflunine is a novel microtubule inhibitor of the vinca alkaloid class currently in
development for the treatment of advanced transitional cell carcinoma of the urothelium …
development for the treatment of advanced transitional cell carcinoma of the urothelium …
Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review
H Gerullis, T Ecke, C Eimer, M Wishahi… - Anti-Cancer Drugs, 2011 - journals.lww.com
The novel third-generation bifluorinated semisynthetic vinca alkaloid, vinflunine, is a
microtubule inhibitor that shows superior antitumor activity and a favorable safety profile …
microtubule inhibitor that shows superior antitumor activity and a favorable safety profile …
Vinflunine: clinical perspectives of an emerging anticancer agent
A Yun-San Yip, E Yuen-Yuen Ong… - Expert opinion on …, 2008 - Taylor & Francis
Background: Vinflunine is a novel second generation of Vinca alkaloid. The binding of
vinflunine to tubulin and subsequent cellular arrest in mitosis is the core mechanism of this …
vinflunine to tubulin and subsequent cellular arrest in mitosis is the core mechanism of this …
Phase II study of single-agent vinflunine in platinum-refractory transitional cell carcinoma of the urothelium (TCCU)
DJ Vaughn, S Srinivas, WM Stadler, R Pili… - Journal of Clinical …, 2007 - ascopubs.org
15543 Background: Vinflunine (VFL) is a new microtubule inhibitor of the vinca alkaloid
class with clinical activity in TCCU (S. Culine, BJC 2006). This trial was conducted to define …
class with clinical activity in TCCU (S. Culine, BJC 2006). This trial was conducted to define …
Vinflunine: review of a new vinca alkaloid and its potential role in oncology
JS Ng - Journal of Oncology Pharmacy Practice, 2011 - journals.sagepub.com
Objective: To review the pharmacology, pharmacokinetics, in vitro and in vivo efficacy, and
safety profile of vinflunine in the treatment of various solid tumors. Data sources: A literature …
safety profile of vinflunine in the treatment of various solid tumors. Data sources: A literature …